Dr. Chris De Savi
Abschluss: Academic Research Fellowship, University of Cambridge
Cambridge, Vereinigte Staaten
Werdegang
Berufserfahrung von Chris De Savi
Bis heute 11 Jahre und 4 Monate, seit März 2013
Associate Director, Oncology Medicinal Chemistry
AstraZeneca
Providing strategic and scientific leadership for both local and global oncology chemistry. Implement improvements in chemistry for the design and delivery of candidate drugs. Training, development and mentoring of scientists and project teams
12 Jahre und 3 Monate, 2001 - März 2013
Drug Discovery Leader
AstraZeneca plc
Design and delivery of candidate drugs in the Oncology Innovative medicines unit and management of a team of senior medicinal chemists
2 Jahre und 6 Monate, Juli 2008 - Dez. 2010
Project Leader
AstraZeneca plc
Responsible for a multi-disciplinary project team and project transition from Lead Optimisation to candidate drug delivery through to early Development - oral and inhaled small molecule projects for the treatment of asthma and COPD
4 Jahre und 9 Monate, Apr. 2006 - Dez. 2010
Drug Design and Team Leader
AstraZeneca plc
Lead medicinal chemist of cross-site drug discovery teams (UK and Sweden) Design and delivery of candidate drugs for the treatment of asthma, COPD and osteoarthritis Change management leader during site re-organisation
Ausbildung von Chris De Savi
2 Jahre und 3 Monate, Mai 1999 - Juli 2001
Organic Chemistry
University of Cambridge
Completed the total synthesis of Laulimalide, a potent anti-microtubule stabilising agent. Research Fellow of Queens' College, Cambridge and organic chemistry tutor for natural science tripos.
3 Jahre und 3 Monate, Jan. 1996 - März 1999
Organic Chemistry
Australian National University
Working with Professor Martin Banwell FRACI, FRSC, FAA. Five peer-reviewed publications associated with PhD thesis. APA(I) scholarship.
5 Jahre, Feb. 1991 - Jan. 1996
Organic and Inorganic Cehmistry
University of Adelaide
Sprachen
Englisch
-